A multicenter study of recombinant factor VIII (recombinate): Safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A

Blood

Volumn 83, Issue 9, 1994, Pages 2428-2435

  Bray, G L ^a   Gomperts, E D ^b   Courter, S ^b   Gruppo, R ^b   Gordon, E M ^b   Manco Johnson, M ^b   Shapiro, A ^b   Scheibel, E ^b   White III, G ^b   Lee, M ^b  

^a BAXTER HEALTHCARE CORPORATION   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8 INHIBITOR; RECOMBINANT BLOOD CLOTTING FACTOR 8;

ARTICLE; BLEEDING; CHILD; CLINICAL TRIAL; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; FEMALE; HEMOPHILIA A; HUMAN; IMMUNOGENICITY; INFANT; MALE; MULTICENTER STUDY; NEWBORN; PRIORITY JOURNAL; RISK; SURVIVAL;

ANTIBODIES; CHILD, PRESCHOOL; FACTOR VIII; HEMOPHILIA A; HUMAN; INFANT; INFANT, NEWBORN; MALE; RECOMBINANT PROTEINS; SUPPORT, NON-U.S. GOV'T;

EID: 0028266130     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)